About the Authors
- Glen S. Hazlewood
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: ggkaplan@ucalgary.ca (GK); gshazlew@ucalgary.ca (GH)
Affiliation Department of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Gyanendra Pokharel
-
Roles Formal analysis, Methodology, Validation, Visualization, Writing – review & editing
Affiliation Department of Mathematics and Statistics, University of Calgary, Calgary, Alberta, Canada
- Robert Deardon
-
Roles Formal analysis, Methodology, Supervision, Visualization, Writing – review & editing
Affiliations Department of Mathematics and Statistics, University of Calgary, Calgary, Alberta, Canada, Department of Production of Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada
- Deborah A. Marshall
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
Affiliation Department of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Claire Bombardier
-
Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing
Affiliations Department of Medicine and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada
- George Tomlinson
-
Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – review & editing
Affiliation Department of Medicine and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada
- Christopher Ma
-
Roles Methodology, Writing – review & editing
Affiliation Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Cynthia H. Seow
-
Roles Methodology, Writing – review & editing
Affiliation Department of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Remo Panaccione
-
Roles Methodology, Writing – review & editing
Affiliation Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Gilaad G. Kaplan
-
Roles Conceptualization, Data curation, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: ggkaplan@ucalgary.ca (GK); gshazlew@ucalgary.ca (GH)
Affiliations Department of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Competing Interests
Dr. Hazlewood, Dr. Pokharel, Dr. Deardon, Dr. Tomlinson and Dr. Ma have nothing to declare. Dr. Marshall has received honoraria and travel expenses from Abbvie, Pfizer, Novartis, and Johnson and Johnson for presentations and participation on advisory boards and has been a consultant for Merck. Dr. Bombardier holds a Pfizer Chair and a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and has received grant support from Janssen, Pfizer, Amgen, Abbott/Abbvie Canada, BMS, Celgene, Eli Lilly, Fresenius Kabi, Hoffman La Roche, Sanofi, UCB, and Calea, has acted as a consultant for AstraZeneca, Abbott/Abbvie Canada and BMS, and has participated in advisory board meetings for Janssen, Pfizer, Amgen, and AstraZeneca. Dr. Panaccione has served as a speaker, a consultant and an advisory board member for Abbott Laboratories, Merck, Schering-Plough, Shire, Centocor, Elan Pharmaceuticals, and Procter and Gamble. He has served as a consultant and speaker for Astra Zeneca. He has served as a consultant and an advisory board member for Ferring and UCB. He has served as a consultant for Glaxo-Smith Kline and Bristol Meyers Squibb. He has served as a speaker for Byk Solvay, Axcan, Jansen, and Prometheus. He has received research funding from Merck, Schering-Plough, Abbott Laboratories, Elan Pharmaceuticals, Procter and Gamble, Bristol Meyers Squibb, and Millennium Pharmaceuticals. He has received educational support from Merck, Schering-Plough, Ferring, Axcan, and Jansen. Dr. Cynthia H. Seow has served as a speaker and participated in advisory board meetings for Janssen, Abbvie, Takeda, Shire and Ferring. Dr. Kaplan has received honoraria for speaking or consultancy from Abbvie, Janssen, Pfizer, and Takeda. He has received research support from Janssen, Abbvie, GlaxoSmith Kline, Merck, and Shire. He shares a patent: TREATMENT OF INFLAMMATORY DISORDERS, AUTOIMMUNE DISEASE, AND PBC. UTI Limited Partnership, assignee. Patent 62/555,397. 7 Sept. 2017. This patent relates to the potential therapeutic effect of mirtazapine on immune mediated disease such as inflammatory bowel disease. However, mirtazapine is not directly studied in the current publication. This does not alter our adherence to PLOS ONE policies on sharing data.